| |
| |
|
| Insider
Information: |
Goff Brian |
| Relationship: |
Chief Executive Office... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
53,780 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,693,532 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
53,780 |
|
|
| Total
Value |
$1,693,532 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 28.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Baxalta Inc |
BXLT |
EVP and President, Hem... |
2016-06-03 |
0 |
2015-07-01 |
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP & Chief Commercial... |
2021-07-21 |
0 |
2017-06-07 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Chief Executive Office... |
2024-03-05 |
53,780 |
2023-06-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-03-05 |
4 |
AS |
$32.57 |
$135,361 |
D/D |
(4,156) |
53,780 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,500 |
57,936 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-24 |
4 |
AS |
$21.64 |
$165,221 |
D/D |
(7,635) |
49,436 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,018 |
57,071 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-09 |
4 |
AS |
$22.99 |
$277,397 |
D/D |
(12,066) |
40,053 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,527 |
52,119 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-08-08 |
4 |
S |
$25.48 |
$259,335 |
D/D |
(10,178) |
26,592 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-08-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,691 |
36,770 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-06-30 |
4 |
S |
$28.36 |
$324,694 |
D/D |
(11,449) |
14,079 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,528 |
25,528 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(150,832) |
0 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
60,144 |
150,832 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2021-06-08 |
4 |
D |
$177.00 |
$192,222 |
D/D |
(1,086) |
90,688 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,473 |
91,774 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2020-12-16 |
4 |
D |
$157.96 |
$3,379,554 |
D/D |
(21,395) |
67,301 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
40,677 |
88,696 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2020-06-08 |
4 |
D |
$114.61 |
$188,190 |
D/D |
(1,642) |
48,019 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2020-03-02 |
4 |
D |
$90.54 |
$126,847 |
D/D |
(1,401) |
49,661 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,880 |
51,062 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2020-02-07 |
4 |
D |
$102.97 |
$164,134 |
D/D |
(1,594) |
40,182 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2019-06-07 |
4 |
D |
$118.61 |
$194,876 |
D/D |
(1,643) |
41,776 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,428 |
43,419 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2019-02-28 |
4 |
D |
$132.93 |
$89,063 |
D/D |
(670) |
33,991 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2019-02-07 |
4 |
D |
$119.57 |
$190,834 |
D/D |
(1,596) |
34,661 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Commercial Officer |
• – – |
2018-06-08 |
4 |
S |
$118.53 |
$194,982 |
D/D |
(1,645) |
36,257 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
